This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

News

New Serialization Installation at Tredegar

PCI Pharma Services Announces Serialization Installation at Tredegar Manufacturing Center of Excellence

Our Tredegar site is the latest to offer full Serialization services to global customers

PCI Pharma Services is pleased to announce the installation and validation of our latest comprehensive Serialization system, located at our manufacturing Center of Excellence in Tredegar, UK. The investment demonstrates our continued investment in and expansion of market-leading Serialization capabilities. This latest installation increases PCI’s Serialization capability to support clients in advance of implementation dates for the European Falsified Medicines Directive (EU FMD), as well as supply for the US and emerging markets, including countries such as China, Turkey, Brazil, Saudi Arabia and others. The system is compliant to all EU member country requirements for Serialization and specialized labeling, including application and integration of advanced Anticounterfeiting technologies.

The highly flexible technology delivers machine and human-readable coding, tamper evident solutions and Bollini labeling – which in turn is linked to a case loading and aggregation station, with a final aggregation station connecting cases to pallet. PCI is a strong supporter of the advanced use of aggregation to support product security, realizing the significant benefits in packaging operations, as well as the broader pharmaceutical supply chain.

PCI’s site in Tredegar, South Wales, UK already offers excellence in potent manufacturing services for customers globally, and this new Serialization technology further strengthens our comprehensive offering. This investment in the Tredegar facility is part of a significant global initiative to develop the Serialization services across our global network, which will ultimately exceed more than 90 lines.

Commenting on this latest investment, Jim Neville, Director of Operations, Tredegar, stated: “This is an important addition to the site’s capabilities. Being able to offer this fully flexible service and work in partnership with our customers to deliver a trusted, seamless service is critical, and being ahead of the timelines with this offering ensures compliance with the EU FMD.

We have been actively Serializing commercial products for the US, European and international markets for the past six years, and this investment in the Tredegar capabilities continues to demonstrate our market-leading position. The integrated technology strategy enables operators in all PCI’s global locations to operate the same graphical user interface, providing a seamless global service. PCI clients enjoy singular connectivity to all PCI sites through a best-in-class platform. We are dedicated to maintaining a leadership position at the forefront of the Serialization initiative and providing clients with an industry-leading customer experience.

June 25, 2018


PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions

In scavenging for undesired moisture and gases, protective packaging solution enables enhanced shelf life and speed-to-market for pharmaceutical and medical... View Article

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

PCI Expands Clinical Services’ presence with acquisition of California-based Sherpa Clinical Packaging Philadelphia, USA – September 10, 2018 Leading global... View Article

x